What is Artiva Biotherapeutics, Inc.'s EPS (diluted)?

Artiva Biotherapeutics, Inc. (ARTV) reported EPS (diluted) of -$0.95 in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s EPS (diluted) changed year-over-year?

Artiva Biotherapeutics, Inc.'s EPS (diluted) decreased by 14.5% year-over-year, from -$0.83 to -$0.95.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Artiva Biotherapeutics, Inc. ARTV EPS (Diluted)

EPS (Diluted) at other companies

Bristol-Myers SquibbBMY

$1.31+9.2%

Gilead SciencesGILD

$1.61+54.8%

Kyverna Therapeutics, Inc.KYTX

-$0.66+35.9%

Allogene TherapeuticsALLO

-$0.18+35.7%

Immix Biopharma, Inc.IMMX

-$0.18-20.0%

ImmunityBio, Inc.IBRX

-$0.62-313%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s EPS (diluted)?: Artiva Biotherapeutics, Inc. (ARTV) reported EPS (diluted) of -$0.95 in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s EPS (diluted) changed year-over-year?: Artiva Biotherapeutics, Inc.'s EPS (diluted) decreased by 14.5% year-over-year, from -$0.83 to -$0.95.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.